| Literature DB >> 25110468 |
Mercedes O Chan1, Ethan S Sen2, Elizabeth Hardy2, Pauline Hensman3, Edmond Wraith3, Simon Jones3, Tim Rapley4, Helen E Foster5.
Abstract
BACKGROUND: Children with mucopolysaccharidoses (MPS) often have musculoskeletal (MSK) abnormalities. Paediatric Gait, Arms, Legs, and Spine (pGALS), is a simple MSK assessment validated in school-age children to detect abnormal joints. We aimed to identify MSK abnormalities in children with MPS performing pGALS.Entities:
Keywords: Metabolic disease; Mucopolysaccharidoses; Musculoskeletal examination; pGALS
Mesh:
Year: 2014 PMID: 25110468 PMCID: PMC4126068 DOI: 10.1186/1546-0096-12-32
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Overview of the mucopolysaccharidoses (MPS)
| Developmental delay, coarse facial features, dysostosis multiplex, hepatosplenomegaly, death by age 10 years | Alpha-L-iduronidase | Heparan sulfate | |
| Micrognathia, toe walking, moderate coarse facies, possible normal intelligence, death by 20s (phenotype intermediate between I-H and I-HS) | | Dermatan sulfate | |
| Aortic valve disease, joint disease, corneal clouding, normal facies, survive into adulthood | |||
| Severe: Disease course similar to MPS I-H, but clear corneas, aggressive behaviour and developmental delay | Iduronate sulfatase | Heparan sulfate | |
| Mild: Normal or near-normal intelligence, less pronounced physical features | Dermatan sulfate | ||
| Variable intermediate presentation similar to MPS I, from fetal hydrops to mild dysmorphism; dense inclusions in granulocytes | Beta-glucuronidase | Heparan sulfate | |
| Dermatan sulfate | |||
| Similar to MPS I without CNS disease, pachymeningitis cervicalis, death in teens and 20s; Hurler phenotype with marked corneal clouding; mild, moderate and severe expression in different families | N-acetylgalactosamine-4-sulfatase (arylsulfatase B) | Dermatan sulfate | |
| Skeletal disease (bone dysplasia) with short stature, ligamentous laxity, corneal opacities, final height <125 cm | N-acetylgalactosamine-6-sulfatase | Keratan sulfate | |
| Same as IV-A but milder; adult height >120 cm | Beta-galactosidase | ||
| Periarticular masses, nodular synovium, popliteal cyst, large joint effusion | Hyaluronidase 1 | Hyaluronan | |
| Behavioural problems, sleeping disorder, aggression, progressive dementia, mild dysmorphism, coarse hair, clear corneas, survival to adulthood possible | Sulfamidase | Heparan sulfate | |
| Alpha-N-acteylglucosaminidase | |||
| GAC-acteylase | |||
| N-acetylglucosamine-6-sulfatase | |||
Musculoskeletal abnormalities detected by pGALS (number of abnormal observations to total observations)
| 49/54 (91%) | 35/39 (90%) | 12/12 (100%) | 2/3 (67%) | ||
| 48/54 (89%) | 36/39 (93%) | 12/12 (100%) | 0/3 (0%) | ||
| 41/54 (76%) | 27/39 (69%) | 12/12 (100%) | 2/3 (67%) | ||
| Reach up | 39/53 (74%) | 26/39 (90%) | 12/12 (100%) | 1/2 (50%) | |
| Open mouth wide and try to put 3 fingers inside | 39/54 (72%) | 28/39 (72%) | 10/12 (83%) | 1/3 (33%) | |
| Hands and wrists together | 37/54 (69%) | 24/39 (62%) | 11/12 (92%) | 2/3 (67%) | |
| Bend forwards. Observe curvature of spine from all sides | 31/50 (62%) | 21/35 (60%) | 8/12 (67%) | 2/3 (67%) | |
| Observe patient standing and then bending forwards | 28/45 (62%) | 22/34 (65%) | 5/9 (56%) | 1/2 (50%) | |
| Observe patient walking | 28/45 (62%) | 20/32 (63%) | 7/10 (70%) | 1/3 (33%) | |
| Hands palm to palm | 33/53 (60%) | 22/39 (56%) | 11/11 (100%) | 0/3 (0%) | |
| Hands out in front | 29/52 (56%) | 17/37 (46%) | 12/12 (100%) | 0/3 (0%) | |
| Touch ear to shoulder | 29/53 (55%) | 17/38 (45%) | 12/12 (100%) | 0/3 (0%) | |
| Hands out in front | 22/40 (55%) | 12/27 (44%) | 9/11 (82%) | 1/2 (50%) | |
| Walk on heels | 24/45 (53%) | 15/33 (45%) | 7/9 (78%) | 2/3 (67%) | |
| Look up to the ceiling | 28/53 (53%) | 19/38 (50%) | 9/12 (75%) | 0/3 (0%) | |
| Turn hand over | 20/42 (48%) | 10/30 (33%) | 9/11 (82%) | 1/1 (100%) | |
| Touch tips of fingers with thumb | 23/54 (43%) | 14/39 (36%) | 8/12 (67%) | 1/3 (33%) | |
| Make a fist | 20/54 (37%) | 10/39 (26%) | 10/12 (83%) | 0/3 (0%) | |
| Put hands behind neck | 12/42 (29%) | 6/27 (33%) | 5/12 (42%) | 1/3 (33%) | |
| Bring ankle up to bottom | 12/44 (27%) | 7/29 (24%) | 4/12 (33%) | 1/3 (33%) | |
| 11/45 (24%) | 4/30 (13%) | 7/12 (58%) | 0/3 (0%) | ||
| Touch tip of finger with thumb | 10/54 (19%) | 5/39 (13%) | 5/12 (42%) | 0/3 (0%) | |
| Put hands and wrists together | 7/53 (13%) | 5/39 (13%) | 2/11 (18%) | 0/3 (0%) | |
| Walk on tip-toes | 4/45 (9%) | 2/33 (6%) | 2/9 (22%) | 0/3 (0%) |
Key: DIP = distal interphalangeal; MCP = metacarpophalangeal; PIP = proximal interphalangeal; pGALS = paediatric Gait, Arms, Legs and Spine; TMJ = temporomandibular joint.
Musculoskeletal abnormalities detected by pGALS in MPS type I (Hurler)
| | 15/15 (100%) | |
| Reach arms up | 13/15 (87%) | |
| Open mouth wide and try to put 3 fingers inside | 13/15 (87%) | |
| Bend forwards. Observe curvature of spine from all sides | 11/15 (73%) | |
| Hands behind neck | 11/15 (73%) | |
| Hands together back to back | 10/15 (67%) | |
| Reach up | 9/15 (60%) | |
| Observe patient walking | 9/15 (60%) | |
| Hands and wrists together | 8/15 (53%) | |
| Look up to the ceiling | 7/15 (47%) | |
| Hands palm to palm | 6/15 (40%) | |
| Hands out in front | 6/15 (40%) | |
| Walk on heels | 6/15 (40%) | |
| Hands out in front | 4/11 (36%) | |
| Touch ear to shoulder | 5/15 (33%) | |
| Turn hand over | 4/12 (33%) | |
| Touch tips of fingers with thumb | 4/15 (27%) | |
| Bring ankle up to bottom | 2/14 (14%) | |
| 1/15 (7%) | ||
| Put hands behind neck | 1/15 (7%) | |
| Put hands and wrists together | 1/15 (7%) | |
| Walk on tip-toes | 0/15 (0%) | |
| Make a fist | 0/15 (0%) | |
| Touch tip of finger with thumb | 0/15 (0%) |
Figures stated as number of abnormal observations to number of total observations.
Musculoskeletal abnormalities detected by pGALS in MPS attenuated type I
| Hands behind neck | 24/24 (100%) | |
| Reach arms up | 23/24 (96%) | |
| Reach up | 17/24 (71%) | |
| Hands together back to back | 17/24 (71%) | |
| Hands palm to palm | 16/24 (67%) | |
| Hands and wrists together | 16/24 (67%) | |
| Observe patient walking | 11/17 (65%) | |
| Open mouth wide and try to put 3 fingers inside | 15/24 (62%) | |
| | 7/19 (56%) | |
| Bend forwards. Observe curvature of spine from all sides | 10/19 (53%) | |
| Look up to the ceiling | 12/23 (52%) | |
| Touch ear to shoulder | 12/23 (52%) | |
| Hands out in front | 11/22 (50%) | |
| Hands out in front | 8/16 (50%) | |
| Walk on heels | 9/18 (50%) | |
| Make a fist | 10/24 (42%) | |
| Touch tips of fingers with thumb | 10/24 (42%) | |
| Put hands behind neck | 5/12 (42%) | |
| Turn hand over | 6/18 (33%) | |
| Bring ankle up to bottom | 5/15 (33%) | |
| 3/15 (20%) | ||
| Touch tip of finger with thumb | 5/24 (21%) | |
| Put hands and wrists together | 4/24 (17%) | |
| Walk on tip-toes | 2/18 (11%) |
Musculoskeletal abnormalities detected by pGALS in MPS type II
| Reach arms up | 12/12 (100%) | |
| Hands behind neck | 12/12 (100%) | |
| Reach up | 12/12 (100%) | |
| Hands together back to back | 12/12 (100%) | |
| Hands palm to palm | 11/11 (100%) | |
| Hands out in front | 12/12 (100%) | |
| Touch ear to shoulder | 12/12 (100%) | |
| Hands and wrists together | 11/12 (92%) | |
| Open mouth wide and try to put 3 fingers inside | 10/12 (83%) | |
| Make a fist | 10/12 (83%) | |
| Hands out in front | 9/11 (82%) | |
| Turn hand over | 9/11 (82%) | |
| Walk on heels | 7/9 (78%) | |
| Look up to the ceiling | 9/12 (75%) | |
| Observe patient walking | 7/10 (70%) | |
| Bend forwards. Observe curvature of spine from all sides. | 8/12 (67%) | |
| Touch tips of fingers with thumb | 8/12 (67%) | |
| | 5/9 (56%) | |
| Touch tip of finger with thumb | 5/12 (42%) | |
| Put hands behind neck | 5/12 (42%) | |
| Bring ankle up to bottom | 4/12 (33%) | |
| 7/12 (58%) | ||
| Walk on tip-toes | 2/9 (22%) | |
| Put hands and wrists together | 2/11 (18%) |
Figure Key: ANA = antinuclear antibody; ESR = erythrocyte sedimentation rate; IDUA = iduronidase, alpha-L; JIA = juvenile idiopathic arthritis; NSAIDs = non-steroidal anti-inflammatory drugs; pGALS = paediatric Gait, Arms, Legs and Spine; RA = rheumatoid arthritis; uGAG = urinary glycosaminoglycans.
Figure 1Suggested Revisions (highlighted yellow with asterisk*) to Existing Algorithm for Evaluation of Joint Contractures in Children. Adapted from Cimaz et al. [17].